// App-Quantinova.ai

1866 ⋆ : Hepatitis B core‐related antigen (HBcrAg) is useful marker in HBV/HDV co‐infection and can help to predict response to pegylated interferon therapy

Researchers

Presenter

  • Ivana Carey

Principal Investigators

  • Matthew Bruce

  • Sarah Montague

  • Michelle Spaan

  • Ruth Byrne

  • Kate Childs

  • Bo Wang

  • Geoffrey M. Dusheiko

  • Kosh Agarwal

Medical Centers

  • Institute of Liver Studies, Kings CollegeHospital NHS Trust, London , United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Hepatitis B

Biomarkers

  • Hepatitis B surface antigen

  • Serum hepatitis B virus DNA

  • Hepatitis B core-related antigen

Drug/Treatment

  • Interferon

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved